http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102676638-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa783eb077323e5ca6a1d18544900715
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2011-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0af8f196e38a8106773b5c8163dc9b23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57017dd0e64fda0445ab080a4e402b0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9149bb05540b7756ba536bd0f2d61ab6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_103635a4cf13c331894beb7742625eec
publicationDate 2014-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102676638-B
titleOfInvention Method and kit for detecting drug-resistance mutation site of ABL kinase domain of BCR/ABL fusion gene
abstract The invention relates to the biological technical field, which discloses an amplification primer for detecting a drug-resistance mutation site of an ABL kinase domain of a BCR/ABL fusion gene. The upstream primer of the amplification primer has a nucleotide sequence shown in SEQ ID No. 1 or SEQ ID No. 2, and the downstream primer of the amplification primer has a nucleotide sequence shown in SEQ ID No. 3. The invention also discloses a method and kit for detecting a drug-resistance mutation site of an ABL kinase domain of a BCR/ABL fusion gene. The invention amplifies the BCR/ABL fusion gene of patients with chronic myelogenous leukemia (CML) by one-step polymerase chain reaction (PCR) amplification, and carries out sequencing by using a specific sequencing primer; and can detect more than twenty kinds of common drug-resistance mutations of the ABL kinase domain of the BCR/ABL fusion gene in a reaction system, which lowers experiment cost, greatly improves accuracy and sensitivity of gene sequencing results, and has a large-scale application prospect.
priorityDate 2011-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2186901-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1KVQ9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5740235
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID110279
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TKU7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID540876
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID417181
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID491292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547014
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID944808
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06SH2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534036
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100000720
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID106480993
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID613
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID61754489
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID568320
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID464802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454269980
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20EU8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11350
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9999
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCCAA26441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123596
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID45821
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID311860

Total number of triples: 43.